News Focus
News Focus
icon url

supersteve13

10/07/22 5:08 PM

#520121 RE: sentiment_stocks #520119

yes- and it would reduce competition for trial-eligible patients by different trials. I work in this space and it's a real problem, especially in cancers with incidence < 75,000 per year in US (for example).
icon url

OilPatch

10/08/22 2:36 AM

#520241 RE: sentiment_stocks #520119

Great... thanks for your opinion.